Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA
This meta-analysis of all CVOTs conducted with oral and parenteral semaglutide to date revealed that the use of semaglutide as a molecule resulted in a significant 21% reduction in MACE, which was driven by reduction in CV death (HR 0.79, 95% CI 0.610.90)
Real-world data suggest that patients treated with GLP-1 receptor agonists may experience neutral or slightly reduced AF-related hospitalizations compared with other glucose-lowering therapies
In short, GM is involved in gut-brain communication via neurological and immunological mechanisms and thus alters bone metabolism and health through the regulation of the enteric nervous system and central nervous system
Patients often experience improved exercise tolerance due to weight loss, enhancing overall fitness and heart health
Gently swirl the vialdo not shaketo avoid damaging peptide structure and ensure even dissolution